Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (but)(2) Camp
2. Adenosine-3',5'-monophosphate, Dibutyryl
3. Amp, Dibutyryl Cyclic
4. Bucladesine
5. Bucladesine, Barium (1:1) Salt
6. Bucladesine, Disodium Salt
7. Bucladesine, Monosodium Salt
8. Bucladesine, Sodium Salt
9. Cyclic Amp, Dibutyryl
10. Dbcamp
11. Dibutyryl Adenosine 3',5' Monophosphate
12. Dibutyryl Adenosine 3,5 Monophosphate
13. Dibutyryl Adenosine-3',5'-monophosphate
14. Dibutyryl Cyclic Amp
15. Disodium Salt Bucladesine
16. Monosodium Salt Bucladesine
17. N',o' Dibutyryl Camp
18. N',o'-dibutyryl-camp
19. N(6),0(2')-dibutyryl Cyclic Amp
20. Sodium Salt Bucladesine
1. Bucladesine
2. 16980-89-5
3. Sodium Dibutyryl Camp
4. Bucladesine Sodium Salt
5. Dibutyryl-camp Sodium Salt
6. Dibutyryl-camp
7. Bucladesine Sodium [jan]
8. Dibutyryl-camp, Sodium Salt
9. Mls000028684
10. 4dzn2c97a7
11. Bucladesine (sodium)
12. Dt-5621
13. Smr000058940
14. Bucladesine Sodium (jan)
15. N6,2'-o-dibutyryladenosine 3',5'-cyclic Monophosphate Sodium Salt
16. Mls001148197
17. Actosin
18. Actosin (tn)
19. N6,2'-o-dibutyryladenosine-3',5'-cyclic Monophosphate Sodium Salt
20. Dt 5621 Sodium Salt
21. 19436-29-4
22. Dibutyl Camp Sodium Salt
23. Dibutyl Cyclic Amp Sodium
24. Unii-4dzn2c97a7
25. Dibutyl Cyclic Amp Sodium Salt
26. Monosodium Dibutyryl Cyclic Amp
27. Sodium Dibutyryl 3',5'-camp
28. Einecs 241-059-4
29. Einecs 243-065-2
30. Dibutyryl 3',5'-cyclic Amp Sodium
31. Sodium Dibutyryl 3',5'-cyclic Amp
32. Dbcamp.na
33. Mfcd00005843
34. N6-02'-dibutyrycyclic Amp, Sodium Salt
35. N6,o2'-dibutyry Cyclic Amp, Sodium Salt
36. Opera_id_1706
37. Sodium;[(4ar,6r,7r,7ar)-6-[6-(butanoylamino)purin-9-yl]-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl] Butanoate
38. Bucladesine (sodium Salt)
39. Schembl93707
40. Mls002207119
41. Mls006010661
42. Sodium Dibutyryl Cyclic Adenosine-3',5'-monophosphate
43. Chembl1522836
44. Chebi:31313
45. Dibutyryl Cyclic Amp Sodium
46. Hms2231c19
47. Hms3403a19
48. Hms3412m09
49. Bucladesine Sodium [mart.]
50. Bucladesine Sodium [who-dd]
51. Hy-b0764
52. Bucladesine Sodium Salt [mi]
53. Dc2797
54. N-6,o-2'-dibutyryladenosine Cyclic 3',5'-monophosphate Sodium Salt
55. Akos024456413
56. Adenosine, N-(1-oxobutyl)-, Cyclic 3',5'-(hydrogen Phosphate) 2'-butanoate, Monosodium Salt
57. Adenosine, N-(1-oxobutyl)-, Cyclic 3',5'-(hydrogen Phosphate) 2'-butanoate, Sodium Salt
58. Adenosine, N-(1-oxobutyl)-, Cyclic 3',5'-(hydrogen Phosphate)-2'-butanoate, Monosodium Salt
59. Ac-31719
60. D01238
61. Q27259467
62. Sodium Dibutyryl Adenosine-3,5-cyclic Phosphate
63. 4h-furo[3,2-d]-1,3,2-dioxaphosphorin, Adenosine Deriv
64. Dibutyryl Adenosine Cyclic Monophosphate Sodium Salt
65. N-6,o-2'-dibutyryladenosine-3'5'-cyclic Monophosphate, Sodium Salt
66. N6,o2'-dibutyryl Adenosine 3',5'-cyclic Monophosphate Sodium Salt
67. Adenosine 3',5'-cyclic Monophosphate, N,o2'-dibutyryl-, Sodium Salt - Cas 16980-89-5
68. N6,2'-o-dibutyryladenosine 3',5'-cyclic Monophosphate Sodium Salt, >=96% (hplc), Powder
69. N6,2'-o-dibutyryladenosine 3',5'-cyclic Monophosphate Sodium Salt, >=97% (hplc), Powder
70. Butyramide, N-(9-beta-d-ribofuranosyl-9h-purin-6-yl)-, Cyclic Hydrogen Phosphate, Butyrate (ester), Monosodium Salt
71. N-(9-.beta.-d-ribofuranosyl-9h-purin-6-yl)butyramide Cyclic 3',5'-(hydrogen Phosphate) 2'-butyrate Sodium
| Molecular Weight | 491.4 g/mol |
|---|---|
| Molecular Formula | C18H23N5NaO8P |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 8 |
| Exact Mass | 491.11819399 g/mol |
| Monoisotopic Mass | 491.11819399 g/mol |
| Topological Polar Surface Area | 167 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 765 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
C - Cardiovascular system
C01 - Cardiac therapy
C01C - Cardiac stimulants excl. cardiac glycosides
C01CE - Phosphodiesterase inhibitors
C01CE04 - Bucladesine
ABOUT THIS PAGE
A Sodium Dibutyryl Camp manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Dibutyryl Camp, including repackagers and relabelers. The FDA regulates Sodium Dibutyryl Camp manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Dibutyryl Camp API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Dibutyryl Camp supplier is an individual or a company that provides Sodium Dibutyryl Camp active pharmaceutical ingredient (API) or Sodium Dibutyryl Camp finished formulations upon request. The Sodium Dibutyryl Camp suppliers may include Sodium Dibutyryl Camp API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Dibutyryl Camp suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Sodium Dibutyryl Camp Drug Master File in Japan (Sodium Dibutyryl Camp JDMF) empowers Sodium Dibutyryl Camp API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Sodium Dibutyryl Camp JDMF during the approval evaluation for pharmaceutical products. At the time of Sodium Dibutyryl Camp JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Sodium Dibutyryl Camp suppliers with JDMF on PharmaCompass.
Sodium Dibutyryl Camp Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Dibutyryl Camp GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Dibutyryl Camp GMP manufacturer or Sodium Dibutyryl Camp GMP API supplier for your needs.
A Sodium Dibutyryl Camp CoA (Certificate of Analysis) is a formal document that attests to Sodium Dibutyryl Camp's compliance with Sodium Dibutyryl Camp specifications and serves as a tool for batch-level quality control.
Sodium Dibutyryl Camp CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Dibutyryl Camp CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Dibutyryl Camp may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Dibutyryl Camp EP), Sodium Dibutyryl Camp JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Dibutyryl Camp USP).
LOOKING FOR A SUPPLIER?
